{"brief_title": "Clinical Study Of Schizophrenia in Both Men and Women", "brief_summary": "The objective of this study is to evaluate the effectiveness of a marketed drug in the treatment of schizophrenia, as an add-on therapy to antipsychotics over a 12-week period. Subjects with schizophrenia who have been maintained on a stable dose of antipsychotics and who fulfill the screening entrance criteria will have an assessment 1-7 days after the first visit to confirm eligibility.", "condition": "Schizophrenia", "intervention_type": "Drug", "intervention_name": "lamotrigine", "criteria": "Inclusion criteria: - If female, must not be pregnant, or must be incapable of conceiving or be taking steps to prevent conception. - Diagnosis of Schizophrenia - Patients must be taking clozapine monotherapy or other atypical antipsychotic at least 3 months prior to this study. Exclusion criteria: - Patients who are currently taking or have taken antidepressant medication in the last month prior. - Patients who are or have been suicidal or homicidal in the last 6 months. - Patients with a history of autistic disorder or another pervasive developmental disorder - Patients whose condition is due to the direct physiological effects of a substance (e.g. a drug of abuse, a medication) or a general medical condition", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "id": "NCT00071747.xml"}